Healthcare -
Biotechnology - NASDAQ - US
$ 0.3559
0.993 %
$ 4.01 M
Market Cap
-0.01
P/E
CYCC - OPERATING EXPENSES
Operating Expenses CYCC - Cyclacel Pharmaceuticals, Inc.
25.9 M
LAST VALUE
6.21%
2 YEAR CAGR
21.68%
5 YEAR CAGR
3.10%
10 YEAR CAGR